Greenbelt, Maryland Clinical Trials

A listing of Greenbelt, Maryland clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 56 clinical trials
Phase 2 Study of SAR439859 Versus Physician's Choice in Locally Advanced or Metastatic ER-positive Breast Cancer (AMEERA-3)

Primary Objective: To determine whether SAR439859 per os improves progression free survival (PFS) when compared with a endocrine monotherapy of the choice of the physician, in participants with metastatic or locally advanced breast cancer. Secondary Objectives: To compare the overall survival in the 2 treatment arms To assess the objective …

targeted therapy
tamoxifen
adenocarcinoma
estrogen receptor-positive breast cancer
er-positive breast cancer
Investigational Site Number 8400036
 (9.2 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +130 other locations
A Trial For The Study of Falciparum Malaria Protein 013 Administered Via Intramuscular Injection in Healthy Adults

A Phase 1, open label clinical study to evaluate the safety, immunogenicity, tolerability and efficacy of Plasmodium falciparum Malaria Protein 013 (FMP013) combined with (ALF with QS-21), saponin molecule derived from the bark of Quillaja species (ALFQ)) in healthy adult volunteers at different doses and dosing schedules.

WRAIR, Clinical Trials Center
 (8.8 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
qa123  

dfdf

14, SIHS Colony Rd, TNHB Colony, TNHB Housing Unit, Neelikonampalayam, Tamil Nadu 641014
 (9.6 away)
  • 0 views
  • 19 Feb, 2024
  • +4 other locations
Determinants of Neonatal Anemia in Women Carrying Multiples

Multiple births in the United States are rapidly increasing in large part due to assisted reproductive technologies. Recent data indicate that multiple births now comprise 3-4.5% of all births in the United States. Pregnant women are at risk for iron (Fe) deficiency anemia yet there are virtually no data on …

Accepts healthy volunteers
14, SIHS Colony Rd, TNHB Colony, TNHB Housing Unit, Neelikonampalayam, Tamil Nadu 641014
 (9.6 away) Contact site
  • 0 views
  • 10 Jan, 2025
  • +2 other locations
Trial T2 User Test Test1234 (fdg)  

dfgfdg

14, SIHS Colony Rd, TNHB Colony, TNHB Housing Unit, Neelikonampalayam, Tamil Nadu 641014
 (9.6 away)
  • 0 views
  • 24 Apr, 2024
  • 1 location
change - Safety and Tolerability of TOP-N53 Applied on Digital Ulcers in Patients With Systemic Sclerosis (TOP-N53-02)  

change - The main goal of this clinical trial is to learn about how safe the new drug TOP-N53 solution is when it is applied to open wounds on the fingertip (digital ulcers) in people with an uncommon illness that results in hard, thickened areas of skin and additional problems …

14, SIHS Colony Rd, TNHB Colony, TNHB Housing Unit, Neelikonampalayam, Tamil Nadu 641014
 (9.6 away)
  • 0 views
  • 13 Jun, 2025
  • +2 other locations
Test Trial v7.4  

Test Trial v7.4

14, SIHS Colony Rd, TNHB Colony, TNHB Housing Unit, Neelikonampalayam, Tamil Nadu 641014
 (9.6 away)
  • 0 views
  • 24 Mar, 2026
  • 1 location
Regression testing of PS ( DO NOT TOUCH )  

Regression testing of PS ( DO NOT TOUCH )

14, SIHS Colony Rd, TNHB Colony, TNHB Housing Unit, Neelikonampalayam, Tamil Nadu 641014
 (9.6 away)
  • 0 views
  • 25 Mar, 2026
  • 1 location
A Study Evaluating JUV DERM VOLUMA XC Injectable Gel for Correction of Temple Hollowing in Adult Participants Over 22 Years Old

The objectives of this study are to evaluate the safety and effectiveness of Juvederm Voluma XC injectable gel in adult participants seeking correction of temple hollowing

Callender Center for Clinical Research
 (4.0 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +14 other locations
A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes

The purpose of the trial is to assess the efficacy and safety of tirzepatide to dulaglutide in participants with type 2 diabetes and increased cardiovascular risk.

body mass index
tirzepatide
cardiovascular disease
dulaglutide
MedStar Health Research Institute
 (4.4 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +650 other locations